FENTANYL
Internal Derangement
Cairo UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Internal Derangement cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Cairo University | N/A | D |
MIDAZOLAM Cairo University | N/A | D |
DEXTROSE Cairo University | N/A | D |
PROPOFOL Cairo University | N/A | D |
Same molecule, other indications
FENTANYL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →